Tactile Systems Technology Inc (TCMD) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Tactile Systems Technology Inc   (NASDAQ: TCMD)

Select the Financial Report: Select the Period:


Description of Tactile Systems Technology Inc's Business Segments


Tactile Systems Technology Inc. is a specialized medical device company dedicated to the design, manufacture, and sale of innovative therapeutic solutions aimed at improving the quality of life for patients suffering from chronic diseases. With a robust portfolio that encompasses various segments, products, and services, the company effectively addresses the needs of patients around the world. Below is an extensive overview of the segments, products, and services offered by Tactile Systems Technology Inc.

Segments

1. Lymphedema
- Tactile Systems Technologys lymphedema segment is fundamentally centered around the treatment of lymphedema, which results from a buildup of lymphatic fluid, often leading to swelling, discomfort, and restricted movement. The company offers devices that promote lymphatic drainage and alleviate symptoms. These devices aim to provide patients with relief while enhancing mobility and overall quality of life. The focus on clinically proven products ensures that patients receive effective therapeutic solutions.

2. Venous Insufficiency
- The venous insufficiency segment addresses the challenges faced by patients suffering from insufficient blood flow in the lower extremities, often leading to symptoms such as leg swelling, pain, and skin changes. Tactile Systems Technology produces a range of compression garments and pneumatic devices designed to improve venous circulation. These products are crafted for ease of use, making them accessible to patients seeking relief from discomfort associated with venous issues.

3. Pressure Ulcers
- This segment focuses on the prevention and treatment of pressure ulcers, also known as bedsores, which are injuries to skin and underlying tissue resulting from prolonged pressure on the skin. Tactile Systems Technology offers devices that facilitate optimal pressure redistribution and skin care management, significantly reducing the risk of ulcer formation. The company’s commitment to preventing pressure ulcers includes the development of innovative technologies to enhance healing and comfort.

Products

1. Flexitouch
- The Flexitouch device is a pneumatic compression system that delivers a gentle, massage-like compression to the affected areas, stimulating lymphatic drainage. This FDA-approved device is clinically validated, demonstrating its effectiveness in managing lymphedema. The user-friendly design promotes patient adherence and improves clinical outcomes.

2. ACTitouch
- ACTitouch is an advanced air compression device designed to provide relief through massage-like actions that promote blood flow. The device is engineered to meet the needs of patients with venous insufficiency, combining comfort with therapeutic efficacy. Its intuitive operation makes it a valuable tool for patients seeking effective management of their condition.

3. Entr'
- Entr' represents a breakthrough in wearable therapy, resembling conventional compression stockings but enhanced with patented IntelliKnit technology. This feature enables graduated compression, providing targeted support that effectively addresses conditions such as lymphedema and venous insufficiency. The design prioritizes both functionality and aesthetic appeal, encouraging regular use among patients.

4. Soothe & Soften
- The Soothe & Soften line of skincare products is specifically formulated to care for skin subjected to medical devices. These products help alleviate irritation and chafing, thereby enhancing patient comfort. Utilizing dermatologically tested ingredients, the line supports skin integrity and promotes healing in areas affected by device use.

Services

1. Clinical Support
- Tactile Systems Technology extends its commitment to healthcare by providing clinical support to medical professionals. This service includes training on the use of devices, ensuring effective patient management, and aiding in the application of best practices in treatment. The clinical support team collaborates with healthcare providers to optimize therapeutic outcomes for patients.

2. Patient Support
- Recognizing the importance of patient education and compliance, Tactile Systems Technology offers personalized support to individuals using their devices. This service aims to empower patients through education on the correct usage of devices, lifestyle modifications, and strategies for maximized treatment benefits. The support team acts as a resource for patients, helping them navigate their therapeutic journey effectively.

3. Insurance Support
- Navigating insurance can often be a challenge for patients. Tactile Systems Technology assists patients and healthcare professionals in managing insurance-related inquiries and claims. This service ensures that patients gain access to the devices prescribed by their physicians and helps streamline the reimbursement process, alleviating some of the financial burdens associated with their treatment.

Summary

In conclusion, Tactile Systems Technology Inc. stands at the forefront of medical innovation with an extensive array of high-quality medical devices, tailored support services, and skincare products designed for patients grappling with chronic diseases. Their specialized segments for lymphedema, venous insufficiency, and pressure ulcers, combined with committed support services, highlight the company’s dedication to enhancing patient outcomes and improving overall quality of life. Through its clinically validated products and comprehensive patient and clinical support offerings, Tactile Systems Technology continues to make a significant impact on the lives of millions of patients globally.


Composition of Tactile Systems Technology Inc Revenues by Segments

 
Product    167.4 % of total Revenue
Rental Product Service    20.43 % of total Revenue
Lymphedema products    158.52 % of total Revenue
Airway clearance products    29.31 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Product 143.46 167.4 %
Rental Product Service 17.51 20.43 %
Lymphedema products 135.85 158.52 %
Airway clearance products 25.11 29.31 %
Total 85.70 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Product - -
Rental Product Service - -
Lymphedema products 105.93 % 118.34 %
Airway clearance products 94.14 % 92.5 %
Total 8.76 % 14.86 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 7.79 9.08 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total 142 % -




Annual Report on Tactile Systems Technology Inc Divisions, Sales by Country

 
Lymphedema products   Lymphedema products Segment contribution to total sales 84.58 % of total Revenue
Airway clearance products   Airway clearance products Segment contribution to total sales 15.54 % of total Revenue
Private insurers and other payers   Private insurers and other payers Segment contribution to total sales 51.32 % of total Revenue
Veterans Administration   Veterans Administration Segment contribution to total sales 8.81 % of total Revenue
Medicare   Medicare Segment contribution to total sales 24.45 % of total Revenue
Durable medical equipment distributors   Durable medical equipment distributors Segment contribution to total sales 15.54 % of total Revenue


Twelve months ended 2025
TCMD s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Lymphedema products 278.38 84.58 %
Airway clearance products 51.14 15.54 %
Total 329.15 100 %
Private insurers and other payers 168.92 51.32 %
Veterans Administration 29.00 8.81 %
Medicare 80.46 24.45 %
Durable medical equipment distributors 51.14 15.54 %


Twelve months ended 2025
TCMD s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 19.09 5.8 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Lymphedema products 7.33 % -
Airway clearance products 52.1 % -
Total 12.46 % 12.54 %
Private insurers and other payers -3.71 % -
Veterans Administration -6.13 % -
Medicare 51.71 % -
Durable medical equipment distributors 52.1 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.